Bayforest Capital’s Exact Sciences EXAS Stock Holding History

Bayforest Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,731	Closed	-$480K	–	948
2025 Q4	$480K	Buy	+4,731	New	+$380K	0.36%	34
2025 Q2	–	Sell	-926	Closed	-$40.1K	–	801
2025 Q1	$40.1K	Buy	926 +453	+96%	+$22.9K	0.02%	584
2024 Q4	$26.6K	Buy	+473	New	+$29.4K	0.03%	550

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bayforest Capital's EXAS Position: Q1 2026 in Review

Bayforest Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,731 shares — an estimated $480K sold.

Bayforest Capital first reported a position in EXAS in Q4 2024 and held it in 3 quarters. The position peaked at $480K in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Bayforest Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Bayforest Capital sold 4,731 Exact Sciences shares in Q1 2026, an estimated $480K.
Bayforest Capital first reported a position in Exact Sciences in Q4 2024 and held it in 3 quarters.
Bayforest Capital's Exact Sciences position peaked at $480K in Q4 2025.
6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Bayforest Capital's 13F filing for Q1 2026, filed 15 Apr 2026.